Cite
HARVARD Citation
Vesole, D. et al. (n.d.). Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma. British journal of haematology. pp. 52-59. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Vesole, D. et al. (n.d.). Phase I study of carfilzomib, lenalidomide, vorinostat, and dexamethasone in patients with relapsed and/or refractory multiple myeloma. British journal of haematology. pp. 52-59. [Online].